MREO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026 [Accessibility Statement] Skip NavigationFaruqi & Faruqi, LLP Securities Litigation Partner [James (Josh) Wilson] Encourages Investors Who Suffered Losses In Mereo BioPharma To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in [Mereo BioPharma] between June 5, 2023 and December 26, 2025 and would like to discuss your legal ...

New York, New York--(Newsfile Corp. - February 26, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Beyond Meat, Inc. (NASDAQ: BYND) between February 27, 2025 and November 11, 2025, both dates inclusive (the "Class Period"), of the important March 24, 2026 lead plaintiff deadline.SO WHAT: If you purchased Beyond Meat securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingen ...

Core Viewpoint - The article discusses a class action lawsuit against uniQure N.V. related to alleged securities fraud, with a deadline for investors to seek lead plaintiff status by April 13, 2026 [1]. Summary by Sections Lawsuit Details - The lawsuit is on behalf of investors who purchased uniQure securities between September 24, 2025, and October 31, 2025 [1]. - Allegations include that the design of uniQure's Pivotal Study was not fully approved by the FDA and that the company downplayed the likelihood of needing to delay its Biologics License Application (BLA) timeline due to additional studies [1]. Company Disclosure - On November 3, 2025, uniQure disclosed that the FDA no longer agreed that data from Phase I/II studies of AMT-130 would be adequate for BLA submission, leading to uncertainty regarding the BLA submission timeline [1]. - Following this disclosure, uniQure's share price fell by $33.40, approximately 49.33%, from $67.69 on October 31, 2025, to $34.29 on November 3, 2025 [1].

Rosen Law Firm Encourages Franklin BSP Realty Trust, Inc. Investors to Inquire About Securities Class Action Investigation - FBRT [Accessibility Statement] Skip NavigationNEW YORK, Feb. 18, 2026 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Franklin BSP Realty Trust, Inc. (NYSE: FBRT) resulting from allegations that Franklin BSP Realty Trust, Inc. may have issued materially misleading business inf ...

RT Sama Hoole (@SamaHoole)One of these is the ingredient list of an Impossible Burger.One is the Beyond Burger.The other is dog food. https://t.co/u94F2orWTL ...

Core Viewpoint - Rosen Law Firm is reminding purchasers of Beyond Meat, Inc. securities of the upcoming lead plaintiff deadline for a class action lawsuit related to misleading statements made by the company during the specified Class Period [1][5]. Group 1: Class Action Details - The Class Period for the lawsuit is from February 27, 2025, to November 11, 2025, inclusive [1]. - Investors who purchased Beyond Meat securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by March 24, 2026 [3]. Group 2: Allegations Against Beyond Meat - The lawsuit alleges that Beyond Meat made materially false and misleading statements regarding the book value of certain long-lived assets, which exceeded their fair value, indicating a likely need for a material, non-cash impairment charge [5]. - It is claimed that these misstatements could impair Beyond Meat's ability to file periodic reports with the Securities and Exchange Commission in a timely manner [5]. - The lawsuit asserts that when the true details became known, investors suffered damages due to the misleading public statements made by the defendants [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked No. 1 for the number of settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, highlighting the firm's expertise in this area [4].

Core Viewpoint - The upcoming years, particularly 2026, are expected to witness a significant surge in IPO activity, driven by major players like OpenAI, Anthropic, and SpaceX, with forecasts suggesting record valuations for these companies [1][2]. Group 1: IPO Market Outlook - Goldman Sachs predicts 2026 will be a record year for IPOs in terms of absolute dollar value, following a slow 2025 with only 61 companies going public in the U.S. [1] - The Wall Street Journal also anticipates a "blockbuster year" for IPOs, with SpaceX potentially achieving a valuation exceeding $1 trillion [2]. - OpenAI is preparing for a valuation around $1 trillion, reflecting the high expectations for AI-related IPOs [2]. Group 2: Historical Context and Performance - OpenAI's ChatGPT has significantly influenced the AI market, becoming the fastest app to reach 100 million users in just two months, which may contribute to a strong IPO performance [4]. - The average IPO in 2023 had a first-day return of 15%, consistent with historical trends [4]. - Historical examples show that while some IPOs can surge initially, they may also experience substantial declines shortly after, as seen with Beyond Meat and Airbnb [5]. Group 3: Investment Strategies - For investors looking to capitalize on the anticipated IPO wave without selecting individual stocks, the Renaissance IPO ETF is suggested as a viable option [6]. - This ETF provides exposure to recently public U.S. companies, holding stocks for three years post-IPO and rebalancing quarterly [8]. - Although the fund has underperformed the S&P 500 since its inception, it has outperformed during periods of high IPO activity, indicating potential for future gains in 2026 [10].

Core Viewpoint - Pilgrim's Pride reported quarterly earnings of $0.68 per share, missing the Zacks Consensus Estimate of $0.78 per share, and showing a decline from $1.35 per share a year ago, indicating a negative earnings surprise of -12.82% [1] Financial Performance - The company posted revenues of $4.52 billion for the quarter ended December 2025, which was 1.79% below the Zacks Consensus Estimate, and an increase from $4.37 billion year-over-year [2] - Over the last four quarters, Pilgrim's Pride has surpassed consensus EPS estimates three times but has not beaten consensus revenue estimates [2] Stock Performance - Pilgrim's Pride shares have increased approximately 9.7% since the beginning of the year, outperforming the S&P 500's gain of 1.4% [3] - The stock's immediate price movement will largely depend on management's commentary during the earnings call [3] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.85 on revenues of $4.6 billion, while for the current fiscal year, the estimate is $4.51 on revenues of $19 billion [7] - The estimate revisions trend for Pilgrim's Pride was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Food - Meat Products industry, to which Pilgrim's Pride belongs, is currently ranked in the bottom 29% of over 250 Zacks industries, suggesting potential challenges ahead [8] - Another company in the same industry, Beyond Meat, is expected to report a quarterly loss of $0.12 per share, reflecting a year-over-year change of +81.5%, with revenues projected to decline by 19.2% from the previous year [9]

Core Viewpoint - Beyond Meat is facing financial pressure, having fully exited its operations in China while attempting to transform its business through new product launches [1] Financial Performance - For the first three quarters of 2025, Beyond Meat reported a revenue decline of 14.37% year-over-year to $214 million, with net losses widening to $193 million. In Q3 alone, revenue was $70.22 million, and net loss was $111 million, primarily due to decreased sales volume and lower prices [2] Business Developments - In February 2025, the company announced the suspension of its operations in China, laying off 95% of its workforce and closing its Jiaxing factory. By November of the same year, it terminated operations on e-commerce platforms like Tmall, officially completing its exit from the Chinese market. Currently, products are only sold through distributors to clear existing inventory. This adjustment marks a significant step in the company's global strategic contraction [3] Stock Performance - On January 8, 2026, Beyond Meat's stock price experienced a notable increase of 5.71%, closing at $0.987 per share with a trading volume of 24.58 million shares. This price fluctuation may be linked to market sentiment regarding the company's transformation progress [4] Strategic Initiatives - In January 2026, Beyond Meat launched a new protein beverage called "Beyond Immerse," aiming to break through the limitations of plant-based meat and expand its innovative protein solutions. The CEO, Ethan Brown, stated the goal is to achieve positive core profitability by the end of 2026 through cost reduction and product diversification [5] Institutional Perspectives - As of January 2026, the majority of brokerage firms have issued sell recommendations, with 57% of institutions holding a bearish outlook, reflecting cautious sentiment regarding the company's fundamentals. Future attention will be needed on the effectiveness of its transformation measures and quarterly financial results [6]

RR SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Richtech Robotics (RR) Investors of Securities Class Action Deadline on April 3, 2026 [Accessibility Statement] Skip NavigationFaruqi & Faruqi, LLP Securities Litigation Partner [James (Josh) Wilson] Encourages Investors Who Suffered Losses In Richtech To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in [Richtech] between January 27, 2026 and 12:00 PM ET on January 29, 2026 and would like to discuss your lega ...